GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.04G096500	P08837	Cysteinyl-Alanine	2	1.79177108521249e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P10628		2	1.17664591268574e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P10799		2	1.2921057183268e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P14255		2	1.68909868257119e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P15181	Swietenitin E	2	3.68558718968756e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P21688	WF 14861	2	7.68870451514e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P28246	PA(2:0/PGJ2)	2	3.8193639244444e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P33312	Longirostrerone C	2	3.67085372127796e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P49964	Lupeol beta-phenyl propionate	2	1.40438287224874e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P00008		1	2.67458624201106e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P01915	Cardiospermin	1	7.37553854194058e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P02046	2-Methyl-4'-(methylthio)-2-morpholinopropiophenone	1	5.98683305187234e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P03711	Monodictyochrome A	1	7.10041910789986e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P04486	Impromidine	1	6.22701953574189e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P06065	4-Toluenesulfonamide	1	6.11120239688165e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P06443		1	4.9884169892736e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P06589	Imazapyr	1	3.31459754296301e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P06861	Idrapril	1	1.80120369486384e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P10193	Luteolin 5-glucoside	1	5.18950850019573e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P15114		1	2.92892179391063e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P15227	6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide	1	6.14346275238786e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P15315	Faratroside	1	1.34735003722496e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P15955	Sildenafil	1	7.61496457708326e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P17415	N-Hydroxy-MeIQx	1	4.57901459647221e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P17499	2-(2-Phenylethenylsulfonyl)ethenylbenzene	1	1.8882024868785e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P18485		1	4.48033519909948e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P19976	BMS 181532	1	3.68532220583032e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P19987	Juncin K	1	9.04295630638507e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P20147	Shoreaphenol	1	3.77408542760037e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P22004	(E)-2-Tridecene-4,6,8-triyn-1-ol	1	2.02917146700272e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P22110	Syringic acid glucuronide	1	4.82539726079011e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P22795	Rhodiolinin	1	5.8813434992969e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P23030	Hexanoyl-L-carnitine	1	5.44198734827878e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P24299	Psilostachyin C	1	3.75639917822683e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P24676	1-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol	1	8.75305905125627e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P24990	2-O-Feruloylhydroxycitric acid	1	4.56737411596377e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P25093	Protorubradirin	1	8.1305538804656e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P25789	10-Isovaleryl kanokoside C	1	7.63864161467852e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P25984	Longicalycinin A	1	6.96779314362406e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P26645	(+)-Pinoresinol 4-O-[beta-D-Glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside]	1	9.49120930407955e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P26788	Gliclazide	1	4.34744771174775e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P28564	3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole	1	5.14791755410056e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P28624	Hedychilactone A	1	5.44571282741234e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P29209		1	4.53123461882714e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P29935	Acantrifoside A	1	5.0995384324556e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P30531	Broussoflavonol E	1	7.88699014886541e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P31334		1	3.96968541948107e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P31781	Fluenetil	1	4.34720310319148e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P33750	6,8-Epoxy-p-menthane	1	9.34285773025948e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P34249	Ethylenediaminetetraaceticacid	1	2.34790787432089e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P35343	3,5,7-Tris(acetyloxy)-8-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one	1	8.87116115577919e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P35356	Aglatenin	1	3.86769155887814e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P37209	2,3-di-O-hexanoyl-alpha-glucopyranose	1	6.15203256394389e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P37295	Parvistemin C	1	4.94673825975272e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P37300	Mulberrofuran P	1	8.90080324315782e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P38057	LysoPE(18:4(6Z,9Z,12Z,15Z)/0:0)	1	4.20767557732604e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P38156	Montanastatin	1	8.67877260616047e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P39715	Soyasaponin aa	1	7.50294764713984e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P39796	(2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid	1	7.12464462623755e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P40246	Bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate	1	7.57864951429794e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P40383	Dimethylphysostigmine	1	9.45447805595792e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P40705	Euphornin G	1	2.08678106486784e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P41645	PI(TXB2/16:2(9Z,12Z))	1	2.58369677894074e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P41812		1	5.79315735156406e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P44581		1	8.17099895291241e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P45697	Cadalene	1	4.84928781781443e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P45751	N-Acetyl-6-O-L-fucosyl-D-glucosamine	1	4.61474081491158e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P46800		1	3.68621346794833e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P47330	Tschimganical A	1	5.97037419799539e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P48276	[R-(E)]-4-(4-Methyl-3-cyclohexen-1-yl)-3-penten-2-one	1	2.73549871682149e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P48915	Noberastine	1	5.42875125213757e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P49188	N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate	1	3.84059004256463e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P51784		1	3.95613551403363e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P51854	Augustine	1	6.42822548768476e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P52181	7,8-Dihydrokavain	1	1.92437529946728e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.04G096500	P53839	Valproic acid glucuronide	1	2.90081523832638e-11	overlap	1e-10	<	Wm82.a2.v1